We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smart CPR Device Aims to Restart More Hearts

By HospiMedica International staff writers
Posted on 29 Jul 2025

Each year in the United States, approximately 600,000 people experience sudden cardiac arrest (SCA), with over 350,000 occurring outside hospitals. More...

Sadly, three out of four of these out-of-hospital cardiac arrests (OHCA) do not survive to hospital admission due to the inability of rescuers to restart the patients' hearts. A critical barrier to successful resuscitation is the lack of real-time, accurate assessment of blood flow to the heart during CPR. Diastolic blood pressure (DBP), which indicates the heart's blood supply during chest compressions, typically requires invasive arterial catheters, especially in prehospital settings. Even when catheters are in place, chest compressions can distort DBP readings, rendering bedside monitors unreliable. Now, researchers are developing a wearable device that measures DBP noninvasively in real time and provides feedback to rescuers, enabling them to personalize CPR for each patient and improve survival chances.

The University of Michigan Max Harry Weil Institute for Critical Care Research and Innovation (Ann Arbor, MI, USA) is leading the development of the device, called INSIGHT-CPR, with funding from the American Heart Association (Dallas, TX, USA). The technology integrates a wearable sensor adapted from earlier prototypes with a neural network trained on arterial waveform data to detect DBP in real time. The sensor, worn on the wrist or finger, transmits data wirelessly to a mobile device, offering live feedback on how well blood is flowing to the heart. This allows rescuers to optimize their resuscitation efforts, including adjusting hand placement or medication timing. The INSIGHT-CPR project is still in the development and preclinical testing phase. Data from adult and pediatric cardiac arrest cases—including in-hospital and out-of-hospital events—will be used to train and validate the AI model.

The AI model is being trained on diverse waveform datasets, including those from prehospital catheterization cases, CHOP’s ICU-resus pediatric study, and Michigan Medicine’s in-hospital data. The device will be tested in large animal models to evaluate compatibility with defibrillation and accuracy in measuring DBP during CPR. Researchers aim to compare DBP-directed CPR using the device against standard life support protocols in terms of effectiveness. Once validated, the solution is expected to eliminate the need for invasive monitoring during resuscitation, filling a major gap in emergency medicine. The team envisions future deployment in prehospital, EMS, and combat casualty care settings, especially those lacking reliable connectivity.

“Our goal with INSIGHT-CPR is to fundamentally change how cardiac arrest is treated by removing the need for invasive monitoring, taking out the guesswork for rescuers and tailoring resuscitation strategies to the patient. Even if we can save an additional 10% of cardiac arrest patients, that’s over 60,000 more lives saved each year. But we’re hoping to achieve much more than that,” said Dr. Cindy Hsu, the project Principal Investigator.

Related Links:
Max Harry Weil Institute for Critical Care Research and Innovation
American Heart Association


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.